Roche Pines For The Rest Of Genetech
LONDON - A dip in the share price of Roche looked like a small price to pay Monday as the Swiss pharmaceutical company offered billions for an American biotech that could help keep its drugs pipeline flowing. Roche (other-otc: RHHBY - news - people ) said Monday that it was buying all outstanding shares in its American partner Genentech, for $43.7 billion in cash, or $89.00 a share, to strengthen its position in cancer drugs. But Roche’s shares fell as investors worried about the cost of th
Tags: Avian Flu, avian-flu-diary, Bird Flu, creative, diary, emergence, flu-pandemic, future, genesis, h5n1, …
Original post:
Roche Pines For The Rest Of Genetech
Leave a Reply